RNA Supply Chain Solutions
-
T Cell Kit For mRNA On NanoAssemblr Spark
4/14/2022
The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.
-
GenVoy-ILM™ T Cell Kit For mRNA, Ignite™
7/1/2022
GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells.
-
INDe sgRNAs For Preclinical Safety, Toxicity, And Efficacy Studies
11/29/2023
Seamlessly transition from discovery to delivery with INDe sgRNAs. These quality sgRNAs can be synthesized in quantities from milligrams to grams and follow high purity specifications.
-
Plasmid DNA Manufacturing
1/31/2023
As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.
-
Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT
3/13/2025
Having produced over 185,000 DNA lots, including 5,000+ cGMP batches, we are a trusted partner in plasmid DNA production from discovery to commercialization.
-
High-Fidelity Nuclease For Therapeutic Breakthroughs
10/28/2024
The hfCas12Max nuclease offers superior gene editing with high fidelity, broad PAM recognition, minimal off-target effects, and compatibility across cell types for therapeutic applications.
-
Process Chemicals For RNA Drug Manufacturing
Make use of our portfolio of raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.
-
Synthetic Research Grade sgRNA Manufacturing For CRISPR Experiments
11/28/2023
Consistently achieve high editing efficiency and quick turnaround time in as little as 7 days with synthetic sgRNA that pave your way to a successful CRISPR experiment.
-
Enabling mRNA Manufacturing For RNA-Based Vaccines And Therapeutics
2/9/2026
Learn about next-generation RNA polymerases that support diverse cap analog chemistries and modified nucleotides, ensuring high capping efficiency and sequence integrity for complex therapeutics.
-
jetMESSENGER®: mRNA Transfection Reagent For Hard-To-Transfect Cells
3/21/2023
Learn about a highly efficient and gentle mRNA transfection reagent designed for outstanding transfection efficiency in hard-to-transfect cells, finally allowing relevant gene expression experiments in almost all cell types.